The report focuses on the Neurological Disorder Drugs market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Neurological Disorder Drugs market.
Major Players in the Neurological Disorder Drugs market are:
Boehringer Ingelheim GmbH
Bayer AG
Merck & Co.
AstraZeneca
Novartis AG
Teva Pharmaceutical Industries Ltd.
F. Hoffmann-La Roche Ltd.
GlaxoSmithKline plc
On the basis of types, the Neurological Disorder Drugs market is primarily split into:
Antipsychotic
Hypnotic & Sedative
Analgesics
Anticoagulants
Others
On the basis of applications, the market covers:
Hospital
Clinic
Home
Major Regions or countries covered in this report:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2029
Global Neurological Disorder Drugs Market Research Report 2022 - Market Size, Current Insights and Development Trends
Table of Content
1 Neurological Disorder Drugs Market Overview
1.1 Product Overview and Scope of Neurological Disorder Drugs Market
1.2 Neurological Disorder Drugs Market Segment by Type
1.2.1 Global Neurological Disorder Drugs Market Sales and CAGR (%) Comparison by Type (2017-2029)
1.3 Global Neurological Disorder Drugs Market Segment by Application
1.3.1 Neurological Disorder Drugs Market Consumption (Sales) Comparison by Application (2017-2029)
1.4 Global Neurological Disorder Drugs Market, Region Wise (2017-2029)
1.5 Global Market Size (Revenue) of Neurological Disorder Drugs (2017-2029)
1.5.1 Global Neurological Disorder Drugs Market Revenue Status and Outlook (2017-2029)
1.5.2 Global Neurological Disorder Drugs Market Sales Status and Outlook (2017-2029)
1.6 Influence of Regional Conflicts on the Neurological Disorder Drugs Industry
1.7 Impact of Carbon Neutrality on the Neurological Disorder Drugs Industry
2 Neurological Disorder Drugs Market Upstream and Downstream Analysis
2.1 Neurological Disorder Drugs Industrial Chain Analysis
2.2 Key Raw Materials Suppliers and Price Analysis
2.3 Key Raw Materials Supply and Demand Analysis
2.4 Market Concentration Rate of Raw Materials
2.5 Manufacturing Process Analysis
2.6 Manufacturing Cost Structure Analysis
2.6.1 Labor Cost Analysis
2.6.2 Energy Costs Analysis
2.6.3 R&D Costs Analysis
2.7 Major Downstream Buyers of Neurological Disorder Drugs Analysis
2.8 Impact of COVID-19 on the Industry Upstream and Downstream
3 Players Profiles
3.1 Boehringer Ingelheim GmbH
3.1.1 Boehringer Ingelheim GmbH Basic Information, Manufacturing Base, Sales Area and Competitors
3.1.2 Product Profiles, Application and Specification
3.1.3 Neurological Disorder Drugs Market Performance (2017-2022)
3.1.4 Business Overview
3.2 Bayer AG
3.2.1 Bayer AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.2.2 Product Profiles, Application and Specification
3.2.3 Neurological Disorder Drugs Market Performance (2017-2022)
3.2.4 Business Overview
3.3 Merck & Co.
3.3.1 Merck & Co. Basic Information, Manufacturing Base, Sales Area and Competitors
3.3.2 Product Profiles, Application and Specification
3.3.3 Neurological Disorder Drugs Market Performance (2017-2022)
3.3.4 Business Overview
3.4 AstraZeneca
3.4.1 AstraZeneca Basic Information, Manufacturing Base, Sales Area and Competitors
3.4.2 Product Profiles, Application and Specification
3.4.3 Neurological Disorder Drugs Market Performance (2017-2022)
3.4.4 Business Overview
3.5 Novartis AG
3.5.1 Novartis AG Basic Information, Manufacturing Base, Sales Area and Competitors
3.5.2 Product Profiles, Application and Specification
3.5.3 Neurological Disorder Drugs Market Performance (2017-2022)
3.5.4 Business Overview
3.6 Teva Pharmaceutical Industries Ltd.
3.6.1 Teva Pharmaceutical Industries Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.6.2 Product Profiles, Application and Specification
3.6.3 Neurological Disorder Drugs Market Performance (2017-2022)
3.6.4 Business Overview
3.7 F. Hoffmann-La Roche Ltd.
3.7.1 F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base, Sales Area and Competitors
3.7.2 Product Profiles, Application and Specification
3.7.3 Neurological Disorder Drugs Market Performance (2017-2022)
3.7.4 Business Overview
3.8 GlaxoSmithKline plc
3.8.1 GlaxoSmithKline plc Basic Information, Manufacturing Base, Sales Area and Competitors
3.8.2 Product Profiles, Application and Specification
3.8.3 Neurological Disorder Drugs Market Performance (2017-2022)
3.8.4 Business Overview
4 Global Neurological Disorder Drugs Market Landscape by Player
4.1 Global Neurological Disorder Drugs Sales and Share by Player (2017-2022)
4.2 Global Neurological Disorder Drugs Revenue and Market Share by Player (2017-2022)
4.3 Global Neurological Disorder Drugs Average Price by Player (2017-2022)
4.4 Global Neurological Disorder Drugs Gross Margin by Player (2017-2022)
4.5 Neurological Disorder Drugs Market Competitive Situation and Trends
4.5.1 Neurological Disorder Drugs Market Concentration Rate
4.5.2 Neurological Disorder Drugs Market Share of Top 3 and Top 6 Players
4.5.3 Mergers & Acquisitions, Expansion
5 Global Neurological Disorder Drugs Sales, Revenue, Price Trend by Type
5.1 Global Neurological Disorder Drugs Sales and Market Share by Type (2017-2022)
5.2 Global Neurological Disorder Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Neurological Disorder Drugs Price by Type (2017-2022)
5.4 Global Neurological Disorder Drugs Sales, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Neurological Disorder Drugs Sales, Revenue and Growth Rate of Antipsychotic (2017-2022)
5.4.2 Global Neurological Disorder Drugs Sales, Revenue and Growth Rate of Hypnotic & Sedative (2017-2022)
5.4.3 Global Neurological Disorder Drugs Sales, Revenue and Growth Rate of Analgesics (2017-2022)
5.4.4 Global Neurological Disorder Drugs Sales, Revenue and Growth Rate of Anticoagulants (2017-2022)
5.4.5 Global Neurological Disorder Drugs Sales, Revenue and Growth Rate of Others (2017-2022)
6 Global Neurological Disorder Drugs Market Analysis by Application
6.1 Global Neurological Disorder Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Neurological Disorder Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Neurological Disorder Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Neurological Disorder Drugs Consumption and Growth Rate of Hospital (2017-2022)
6.3.2 Global Neurological Disorder Drugs Consumption and Growth Rate of Clinic (2017-2022)
6.3.3 Global Neurological Disorder Drugs Consumption and Growth Rate of Home (2017-2022)
7 Global Neurological Disorder Drugs Sales and Revenue Region Wise (2017-2022)
7.1 Global Neurological Disorder Drugs Sales and Market Share, Region Wise (2017-2022)
7.2 Global Neurological Disorder Drugs Revenue and Market Share, Region Wise (2017-2022)
7.3 Global Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.4 United States Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.5 Europe Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.6 China Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.7 Japan Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.8 India Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.9 Southeast Asia Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.10 Latin America Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
7.11 Middle East and Africa Neurological Disorder Drugs Sales, Revenue, Price and Gross Margin (2017-2022)
8 Global Neurological Disorder Drugs Market Forecast (2022-2029)
8.1 Global Neurological Disorder Drugs Sales, Revenue Forecast (2022-2029)
8.1.1 Global Neurological Disorder Drugs Sales and Growth Rate Forecast (2022-2029)
8.1.2 Global Neurological Disorder Drugs Revenue and Growth Rate Forecast (2022-2029)
8.1.3 Global Neurological Disorder Drugs Price and Trend Forecast (2022-2029)
8.2 Global Neurological Disorder Drugs Sales and Revenue Forecast, Region Wise (2022-2029)
8.2.1 United States Neurological Disorder Drugs Sales and Revenue Forecast (2022-2029)
8.2.2 Europe Neurological Disorder Drugs Sales and Revenue Forecast (2022-2029)
8.2.3 China Neurological Disorder Drugs Sales and Revenue Forecast (2022-2029)
8.2.4 Japan Neurological Disorder Drugs Sales and Revenue Forecast (2022-2029)
8.2.5 India Neurological Disorder Drugs Sales and Revenue Forecast (2022-2029)
8.2.6 Southeast Asia Neurological Disorder Drugs Sales and Revenue Forecast (2022-2029)
8.2.7 Latin America Neurological Disorder Drugs Sales and Revenue Forecast (2022-2029)
8.2.8 Middle East and Africa Neurological Disorder Drugs Sales and Revenue Forecast (2022-2029)
8.3 Global Neurological Disorder Drugs Sales, Revenue and Price Forecast by Type (2022-2029)
8.3.1 Global Neurological Disorder Drugs Revenue and Growth Rate of Antipsychotic (2022-2029)
8.3.2 Global Neurological Disorder Drugs Revenue and Growth Rate of Hypnotic & Sedative (2022-2029)
8.3.3 Global Neurological Disorder Drugs Revenue and Growth Rate of Analgesics (2022-2029)
8.3.4 Global Neurological Disorder Drugs Revenue and Growth Rate of Anticoagulants (2022-2029)
8.3.5 Global Neurological Disorder Drugs Revenue and Growth Rate of Others (2022-2029)
8.4 Global Neurological Disorder Drugs Consumption Forecast by Application (2022-2029)
8.4.1 Global Neurological Disorder Drugs Consumption Value and Growth Rate of Hospital (2022-2029)
8.4.2 Global Neurological Disorder Drugs Consumption Value and Growth Rate of Clinic (2022-2029)
8.4.3 Global Neurological Disorder Drugs Consumption Value and Growth Rate of Home (2022-2029)
8.5 Neurological Disorder Drugs Market Forecast Under COVID-19
9 Industry Outlook
9.1 Neurological Disorder Drugs Market Drivers Analysis
9.2 Neurological Disorder Drugs Market Restraints and Challenges
9.3 Neurological Disorder Drugs Market Opportunities Analysis
9.4 Emerging Market Trends
9.5 Neurological Disorder Drugs Industry Technology Status and Trends
9.6 News of Product Release
9.7 Consumer Preference Analysis
9.8 Neurological Disorder Drugs Industry Development Trends under COVID-19 Outbreak
9.8.1 Global COVID-19 Status Overview
9.8.2 Influence of COVID-19 Outbreak on Neurological Disorder Drugs Industry Development
10 Research Findings and Conclusion
11 Appendix
11.1 Methodology
11.2 Research Data Source
Global Loratadine Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 01-Jun-2023 Price: US 3260 Onwards Pages: 130
Loratadine is an antihistamine that reduces the effects of natural chemical histamine on the body. Histamine can produce symptoms of sneezing, itching, watery eyes and runny nose. Loratadine is used to treat sneezing, runny nose, tears, hives, rashes, itching and other cold or allergy symptoms. Loratadine is also used to treat urticaria and itching in the skin of people with chronic skin reactions.
The Loratadine market revenue was 145.21 Million USD in 2022, and will reach 210.61 Million......
Global Birch Pollen Allergy Drug Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 01-Jun-2023 Price: US 3260 Onwards Pages: 110
The Birch Pollen Allergy Drug market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Birch Pollen Allergy Drug industry, and breaks down according to the type, application, and consumption area of Birch Pollen Allergy Drug. The report also introduces players in the industry from the perspective of the industry chain and marketing ......
Global Clarityne Market Insights, Forecast to 2029
Published: 31-May-2023 Price: US 4900 Onwards Pages: 109
Clarityne are drugs that alter histamine effects by decreasing the histamine levels or blocking the histamine receptors.
The global Clarityne market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Generally, the histamine 1 or H1 receptor is blocked to minimize the effects of the histamine secreted. It is mostly used to treat any allergic response caused by the hyper secretion of histamin......
Global Desloratadine Market Insights, Forecast to 2029
Published: 31-May-2023 Price: US 4900 Onwards Pages: 95
Desloratadine is an antihistamine that is used to get relieve from allergic symptoms, such as sneezing, runny nose, and rashes due to chronic reactions.
The global Desloratadine market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Desloratadine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period......
Global Clarityne Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 30-May-2023 Price: US 3260 Onwards Pages: 106
The Clarityne market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Clarityne industry, and breaks down according to the type, application, and consumption area of Clarityne. The report also introduces players in the industry from the perspective of the industry chain and marketing chain and describes the leading companies.......
Global Neurological Disorder Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 04-May-2023 Price: US 3260 Onwards Pages: 123
The Neurological Disorder Drugs market revenue was 20805.8 Million USD in 2022, and will reach 27703.72 Million USD in 2028, with a CAGR of 4.89% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Neurological Disorder Drugs industry, and breaks down according to the type, application, and consumption area of Neurological Disorder Drugs. The report also introduces players in the industry from the perspective of the industry c......
Global Allergic Rhinitis Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 27-Apr-2023 Price: US 3260 Onwards Pages: 114
Allergic rhinitis, or hay fever, is an allergic reaction to specific allergens. An allergen is an innocuous substance that causes an allergic reaction. This condition is usually caused by dust, animal dander, pollen, and certain food ingredients.
The Allergic Rhinitis Drugs market revenue was 3956.8 Million USD in 2022, and will reach 5997.75 Million USD in 2028, with a CAGR of 7.18% during 2022-2028.
This report elaborates the market size, market characteristics, and marke......
Global Allergy Rhinitis Drugs Market Insights: Impact of COVID-19 and Future Expectations to 2028
Published: 25-Apr-2023 Price: US 3260 Onwards Pages: 101
Allergic rhinitis, also known as hay fever, is a type of inflammation in the nose which occurs when the immune system overreacts to allergens in the air.
The Allergy Rhinitis Drugs market revenue was XX Million USD in 2022, and will reach XX Million USD in 2028, with a CAGR of XX% during 2022-2028.
This report elaborates the market size, market characteristics, and market growth of the Allergy Rhinitis Drugs industry, and breaks down according to the type, application, and ......
2023-2031 Report on Global Loratadine Market by Player, Region, Type, Application and Sales Channel
Published: 24-Apr-2023 Price: US 2500 Onwards Pages: 103
This report studies the Loratadine market, covering market size for segment by type (USP Standards Grade, EP Standards Grade, etc.), by application (Loratadine Tablet, Loratadine Capsules, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Merck Group, Cadila Pharmaceuticals, Morepen, Ultratech India Limited, Vasudha Pharma Chem, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).
This report provides detailed ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
